Studies on the basis of HIV-1 variation and its prposeful increase
2012-12
Loading...
View/Download File
Persistent link to this item
Statistics
View StatisticsJournal Title
Journal ISSN
Volume Title
Title
Studies on the basis of HIV-1 variation and its prposeful increase
Authors
Published Date
2012-12
Publisher
Type
Thesis or Dissertation
Abstract
Unconventional measures are needed in an effort to outpace the HIV/AIDS pan- demic. Even with access to the six classes of FDA-approved antiretrovirals, adverse drug effects and evolution of drug resistance still pose obstacles, and represent issues that will inevitably arise in the developing world. Along with the absence of a proven vaccine strategy, these shortcomings necessitate the continual search for new therapeutic targets. One such novel approach is to target HIV-1’s low copying fidelity with a deliberate in- crease in viral mutational load using exogenous small molecule mutagens. However, in- asmuch as this concept of viral lethal mutagenesis has gained notoriety, it is also essential to understand fundamental enzymatic components (i.e., reverse transcriptase) that con- tribute to variation. The goal of this dissertation was to advance basic models to better understand the causes and consequences of HIV-1 variation. The components that influence variation within an HIV-1 population structure are critical to predict the emergence and direction of viral evolution (e.g., drug resistance). For these studies, the relationship between viral fitness and mutation rate was investigat-ed. A panel of 10 reverse transcriptase mutants – most having drug resistance pheno- types – were analyzed for their effects based on these two biological properties. Muta- tion rate differences were measured using single-cycle vector assays, while fitness differ- ences were identified using ex vivo head-to-head competition assays. As anticipated, vi- ral mutants possessing either higher or lower mutation rate had a corresponding loss in fitness. These observations provided the first description of an interrelationship between HIV-1 fitness and mutation rate and support the conclusion that mutator and antimutator phenotypes correlate with reduced viral fitness. A second focus of this dissertation was directed at studying novel mechanisms by which viral mutagens diminish HIV-1 infectivity. I have detailed the antiviral mecha- nisms of the ribonucleoside analog 5-azacytidine. It was demonstrated that the primary antiviral activity of 5-azacytidine can be attributed to its effect on the early phase of HIV- 1 replication mediated by reverse transcriptase. Furthermore, the antiviral activity was associated with an increase in the frequency of viral mutants. Sequencing analysis showed enrichment in guanosine-to-cytidine (G-to-C) transversion mutations. These re- sults indicated that 5-azacytidine was incorporated into viral DNA following its 2’-OH reduction to 5-aza-2’-deoxycytidine. Incorporation into the viral DNA led to an increase in mutant frequency, which is consistent with lethal mutagenesis. Lastly, studies were directed at understanding concomitant exposure of two unre- lated mutagenic agents. Because the APOBEC3 proteins’ restrictive nature associated with cytosine deamination, I wanted to investigate its interplay with the small molecule cytosine analog, 5-azacytosine. Reduced viral infectivity and increased viral mutagenesis were observed with both the viral mutagen 5-azacytosine (i.e., G-to-C mutations) and the host restriction factor APOBEC3G (i.e., guanosine-to-adenosine (G-to-A) mutations); however, when combined, they had complex interactions. Nucleotide sequence analysis revealed that concomitant HIV-1 exposure to both 5-azacytosine and APOBEC3G result- ed in an increase in G-to-A viral mutagenesis at the expense of G-to-C mutagenesis. Al- so, APOBEC3G catalytic activity was required for the diminution in G-to-C mutagenesis. These findings provided the first demonstration for potentiation of the mutagenic effect of a cytosine analog by APOBEC3G expression, resulting in concomitant HIV-1 lethal mutagenesis. In summary, the studies conducted in this dissertation 1) provide the first direct experimental evidence of an interrelationship between HIV-1 fitness and mutation rate, 2) demonstrate that the primary antiviral mechanism of 5-azacytidine can be attributed to its ability to increase the HIV-1 mutation frequency through viral DNA incorporation during reverse transcription, and 3) provide the first demonstration for potentiation of the muta- genic effect of a cytosine analog (i.e., 5-azacytosine) by APOBEC3G expression, result- ing in concomitant HIV-1 lethal mutagenesis.
Description
University of Minnesota Ph.D. dissertation. December 2012. Major: Pharmacology. Advisor: Louis M. Mansky. 1 computer file (PDF); xi, 161 pages, appendices I-III.
Related to
Replaces
License
Collections
Series/Report Number
Funding information
Isbn identifier
Doi identifier
Previously Published Citation
Suggested citation
Dapp, Michael J.. (2012). Studies on the basis of HIV-1 variation and its prposeful increase. Retrieved from the University Digital Conservancy, https://hdl.handle.net/11299/143187.
Content distributed via the University Digital Conservancy may be subject to additional license and use restrictions applied by the depositor. By using these files, users agree to the Terms of Use. Materials in the UDC may contain content that is disturbing and/or harmful. For more information, please see our statement on harmful content in digital repositories.